MP Healthcare Venture Management
Investor profile
Investment firm
Deals
7
distinct rounds
Companies
6
backed
Active span
2011–2025
15 yrs
Total round €
€218M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Cambridge Enterprise2
- Novo Holdings2
- 5AM Ventures1
- Agent Capital1
- Arrowfield Capital1
- Boehringer Ingelheim Venture Fund1
- Bristol Myers Squibb1
- Cambridge Innovation Capital1
- Catalio Capital Management1
- Dementia Discovery Fund1
- Eli lilly and company1
- Export and Investment Fund of Denmark (EIFO)1
- Forbion1
- Gilde Healthcare1
- Heyford Trust1
- High-Tech Gründerfonds (HTGF)1
- INKEF Capital1
- Jonathan Milner1
- LifeArc Ventures1
- M Ventures1
- Martlet Capital1
- NRW.BANK1
- o2h Ventures1
- Pfizer Ventures1
- QIA1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| GlycoEra | Switzerland | 1 | €114M |
| GenKyoTex | Switzerland | 2 | €42M |
| Trimtech Therapeutics | UK | 1 | €29M |
| Rigontec | Germany | 1 | €14M |
| Draupnir Bio | Denmark | 1 | €12M |
| PharmEnable | UK | 1 | €6.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| GlycoEra | Series B | €114M | 2025-05 |
| Trimtech Therapeutics | Seed | €29M | 2025-03 |
| GenKyoTex | Series C | €24M | 2012-06 |
| GenKyoTex | Series C | €19M | 2011-04 |
| Rigontec | Series A | €14M | 2016-08 |
| Draupnir Bio | Seed | €12M | 2024-07 |
| PharmEnable | Seed | €6.9M | 2023-05 |